PathAI company overview
About
Expert Vetted Data
Public disclosures rarely capture a company's internal dynamics or the true state of its technology. Gain first-hand insight by speaking with former PathAI executives.
Ownership & Key Financials
Revenue
Investors
Revenue / FTE
Ownership
FTEs
Key Business Breakdowns
Products & Services
AIM-HER2
••••••••• •••••••• ••••••• ••••••••• ••••••••• ••• •••• ••••••••• ••••••••.
AIM-PD-L1
••••••••• •••••••• ••••••• ••••••••• ••••••••• ••• ••-•• ••••••••• ••••••••.
AI Biomarker Discovery Services
•••••••••• •••••••• ••• ••••••••• ••••••••• •• ••••••• •••••••••••••• •••• ••• •••••••• ••••••• ••••••••••.
Diagnostic Development & Commercialization Solutions
••••••••• ••• •••••••••• ••• ••••••••••••••• •••••••••• •••••.
Clinical Trial Services
•••-••-••• •••••••••• •••••••• ••• ••••••••• ••••••••• •• ••••••• •••••••••••••• •••• •• •••••••• ••••••.
PathExplore
•••••••• •• •••••••••• ••• ••• •• •••• ••••••••••• ••••••••.
AISight
PathAI's core product comprising its AISight image management system for AI slide processing; includes FDA-cleared digital pathology image management ••• ••••••• •••••••••.
PLUTO Foundation Model
••••••••• ••••••••• ••••••••••• (•••••), • •••••••••-•••••••• •••••••••• •• ••••• ••••••• •• •••• •••,••• ••••••••• •••••• •••••• ••+ ••••••••.
Pricing & Go-to-market
Typical Contract Length
•••••• •••• • ••••••-• ••••• ••••••••• •• •••••••• ••••, •••• •••••• •••••••••••••• ••••••••• ••••••••• •••••••• •••• •••••• ••••••••••.
Pricing model
License fee model, with fees tailored to each customer’s needs and budget, typically delivered through a white-glove service and service-level agreeme•••, ••••• • •••••••••••• ••••• •• ••••••••• ••• •••• ••••••• •••••••.
Average Sales Value
$••-$•••.
Average Sales Cycle
•. • ••••.
Growth Review
Customer Concentration
••• ••• •• ••••••••• •••••••••• •• •. ••% •• ••••• •••••••.
Customer Retention
••-••%.
Key Purchasing Criteria
••• •••••••••• •••••••••••••• ••••••• •••••••••••, ••••••••••• •••••••••••••, ••• ••• ••• •• •••••••• ••••••••••.
| Company Name | Revenue | FTE | Proprietary Insights | HQ | Ownership Type |
|---|---|---|---|---|---|
 PathAI | - | ••• '•• | - | USA | V•••••••• |
 Indica Labs | - | - | - | - | - |
 Nucleai | - | - | - | - | - |
| | - | - | - | - | - |
 Ibex Medical Analytics | - | - | - | - | - |
 Aiforia Technologies | - | - | - | - | - |
 Proscia | - | - | - | - | - |
| $1•m '•• | •• '•• | - | USA | V•••••••• | |
 Visiopharm | - | - | - | - | - |
 Philips | - | - | - | - | - |
Experts highlight PathAI's operational execution and market approach, while noting capital efficiency requirements as a potential constraint.
What does Origin provide on PathAI?
Origin provides a structured company snapshot of PathAI, combining expert-led insights with analysis across business model, customers, competitors, and market dynamics. The profile is designed to support research, competitive analysis, and commercial due diligence workflows.
How is Origin's analysis of PathAI different from traditional company databases?
Traditional company databases often focus on surface-level metadata such as ownership, funding, and company descriptions. Origin complements these sources with qualitative insights informed by expert interviews, helping teams understand how PathAI operates, competes, and creates value in practice.
Is Origin suitable for researching private companies like PathAI?
Yes. Origin is built to support research on private companies, where public information can be limited or inconsistent. It focuses on insight depth and operational context, which can be useful when evaluating companies like PathAI for investment, partnership, or competitive analysis.
Where does Origin's information on PathAI come from?
Origin insights are derived from expert interviews conducted by Dialectica, combined with structured analysis and secondary validation where appropriate. This approach prioritises first-hand operational perspectives alongside supporting evidence, rather than relying solely on aggregated public data.
Can Origin support commercial due diligence on PathAI?
Origin can support early-stage commercial due diligence by helping teams quickly understand positioning, value drivers, customer dynamics, and potential risks related to PathAI. It is typically used to shape hypotheses and focus areas before deeper primary research.
How does Origin compare to Crunchbase or PitchBook for analysing PathAI?
Crunchbase and PitchBook primarily focus on company metadata, ownership, funding history, and transactions. Origin complements those sources by adding qualitative, insight-led analysis focused on business fundamentals, go-to-market execution, customer reality, and competitive positioning for companies like PathAI.
How do teams use Origin to evaluate VC-backed companies like PathAI?
For VC-backed companies, Origin is often used to assess product differentiation, early go-to-market motion, buyer behaviour, and the credibility of growth narratives. It can help teams understand where PathAI is winning, what is driving adoption, and which constraints may affect scaling.
What does Origin typically reveal about pricing and go-to-market strategy for enterprise software companies like PathAI?
For enterprise software, Origin often focuses on pricing logic, contract structure, buyer personas, procurement friction, and channel strategy. For companies like PathAI, this can help teams assess how revenue is created, what drives expansion, and where sales cycles or retention may impact outcomes.
Relevant Companies
AaNeel
Health management platform for healthcare providers and payer organisations to manage clinical operations, facilitate care coordination, and track value-based care outcomes.
HQ
Ownership
Nextech Systems
Integrated EHR and practice management platform used by private practices and private equity-backed groups in the medical sector, with a focus on dermatology and ophthalmology.